Artificial Intelligence and Machine Learning – Multimedia

Biological and biomedical research used to be a field anchored down by the weight of time-consuming manual tasks. Involved and laborious wet-lab processes slowed output to a crawl.

But now, high-throughput technologies have ramped up the speed of science. In this infographic, we take a deep dive into how these technologies have changed the game.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

Target enrichment allows researchers to selectively capture, sequence and study specific genes or genomic regions. Carefully designed target enrichment probes that hybridize with high specificity and coverage are essential to ensuring workflow efficiency and data quality.

This video shows how researchers trained AI using TikTok dances and the Mannequin Challenge.

Whether you are working in cell line development, 3D biology, drug screening —or a combination of the three — technologies that maximize throughput and reproducibility can free up your time and give you greater insights.

This eBook is an essential read for anyone interested in the evolution of protein engineering and the impact of synthetic DNA on the optimization of protein discovery.

Download this listicle to learn about developments in immunotherapy, AI/machine learning and cancer vaccines.

Download this eBook to discover topics including existing and emerging Lab 4.0 technologies, how to future-proof your LIMS and eight ways to make your lab more sustainable.

In this incredible episode of Opinionated Science, we will discuss the exciting concept of the Lab Of the Future with senior manager of product management at Thermo Fisher Scientific Dean Mulyk.

Artificial intelligence (AI) is changing the game for drug discovery and repurposing. There are currently more than 100 drugs in the AI drug discovery pipeline and numerous more that are making their way to clinical trials in a matter of years—instead of decades.